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LETTER TO THE EDITOR
Sir,
Comparison between the WOMAC and the
Lequesne indices in patients with knee and hip
osteoarthritis
We read with interest the study by G. Stucki
et al [1] on the comparison of the two aforemen-
tioned indices for the assessment of osteoarthritis
(OA) of the hip and knee. We were surprised by
several aspects of that study.
(1) As the authors themselves mentioned, the
algofunctional indices aggregate symptoms and
items of function which are not graded separately.
Then, why has this separation been made? Only the
total score of our indices was proposed, is useful
and largely used.
(2) Above all, if a separation is made without
taking the advice of the ‘fathers’ of the method,
this splitting should be logical and relevant: the
question 1B: ‘discomfort after getting up in the
morning’ had to be treated apart, since it deals
with stiffness. In 1988, N. Bellamy himself did so in
the comparison of his ‘new’ WOMAC and our ‘old’
severity index [2]. He considered question 1B as
belonging to stiffness. Not to have adopted such a
separation is the main cause of the weakness of the
internal consistency of our indices found in that
study (low Cronbach’s coefficient). For us, to put
question 1B in the domain of ‘pain or discomfort’
(and the term ‘discomfort’ is an important
consideration) was a question of offering a
presentation comfortable for the user’s memory
(‘getting up’ comes after ‘night rest’...).
(3) Whether authors integrated part II (walking
distance) of our indices in ‘function’ or not is
unclear.
(4) The algofunctional indices were always
proposed as an interview technique, not a
self-administered or a self-reported one. Our
experience with the self-reported technique was
disappointing [3]. The self-administered report is a
source of bias. In the interview format, misunder-
standings are largely avoided.
(5) Since the German language was used, why
didn’t the authors either adopt the German
translation of the indices published in 1994 [4] or,
at least, explain why they rejected it. We have no
information concerning the formulations used in
that study.
In that study, to conclude that, due to the lack
of internal consistency of part I, the algofunctional
indices are ‘not valid’ as composite indices without
having tested the clinical relevance of the indices
in their total scores seems to us to extrapolate too
far, if not abusive. Bellamy himself compared his
WOMAC and our indices in 1988 and found a good
correlation [2]. Our indices were used for 12 years
in a lot of drug trials worldwide and yielded
satisfactory reproducibility and sensitivity to
change (examples with placebo given in [3]). The
global score allows the investigator to classify
patients according to their grade of clinical
severity at baseline and, in daily practice, to decide
in due time the relevant indication of total hip
replacement, when the score is 10–12 points and
above.
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Author’s Reply
We agree with Professor Lequesne and col-
leagues that the Lequesne indices have been
successfully used in many drug trials, mostly in
Europe, over the last 12 years. Indeed the Lequesne
Indices were among the first patient oriented
outcome instruments and therefore made a
substantial contribution to improved outcome
assessment in osteoarthritis (OA). However, the
science of health status measurement has gone a
long way since then, and most currently used
instruments including the Lequesne indices, the
WOMAC and even the HAQ are likely to be further
developed in the near future, with the goal to
improve their metric properties, which will allow
for parametric analysis and an increase in their
responsiveness.
Our goal indeed was not to criticize a specific
instrument, but to develop a greater under-
standing of the metric properties, similarities and
disparities between the two most widely used OA
instruments, the WOMAC and Lequesne Indices.
This understanding is essential for the above
mentioned further development of these instru-
ments. With this in mind it is clear why we did not
split, but rather examined the parts of the
Lequesne Index. Based on this analysis, an
integration of the Lequesne Index items into one
single index seems questionable, and the main
problem, apart from the question which sub-
dimensions to consider, is as we stated in our
paper, the varying categorization of individual
items. With respect to the administration, whether
as an interview or in self-administered form, we
were interested in the performance of the self
administered instrument. However, it is likely that
the problems with the metric properties of the
Lequesne Index would show up in an interview-
format instrument as well. The same holds true for
the question of the language. With respect to the
language we may mention that we performed a
translation and back-translation following the rule
of cross cultural validation. To the best of our
knowledge such a German validation has not been
performed, although the instrument may have been
used in some German studies.
In conclusion we would like to encourage
further investigation into the performance of the
currently available OA instruments, and hope that
the current instruments will be improved in the
near future, accepting that health status measure-
ment is as all other sciences, moving as well.
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